logo

For the Inventor, By the Inventor

Hermitage, PA, United States of America

Mitchell S Felder

This inventor holds 24 USPTO granted patents and 29 published patent applications, primarily in Biomedical Treatment. Top assignees: Infectech, Inc., Marv Enterprises, LLC, Altman Enterprises, LLC. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitchell S Felder. Retrieved from https://idiyas.com/inventor/mitchell-s-felder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 95.8

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 102(Granted Patents)


Location History:

  • Sharon, PA (US) (1997 - 2001)
  • Hermitage, PA (US) (1997 - 2021)

Company Filing History:

goldMedal18 out of 31 
 
Infectech, Inc.
 patents
silverMedal3 out of 3 
 
Marv Enterprises, LLC
 patents
bronzeMedal1 out of 1 
 
Altman Enterprises, LLC
 patent
4. 1 out of 1 
 
Halberd Corporation
 patent
5. 1 out of 7 
 
Nanologix, Inc.
 patents

Years Active: 1997-2026

Loading Chart...
Areas of Expertise:
Cytokine Storms
Antibody Binding
Bodily Fluids
Cockayne Syndrome
Blood Carcinomas
Microorganism Sensitivity
Antimicrobial Agents
Apoptosis Induction
Hydrogen Production
Testing Apparatus
Treatment Methods
24 patents (USPTO):Explore Patents
1. 12521475 - Method, Device, and Product for Treating a Body Fluid of a Patient with an Inflammatory Cytokine Storm by Binding an Antibody to a Cytokine Antigen in the Body Fluid to Form an Antigen-Antibody Complex That Is Removed from the Body Fluid to Reduce the Amount of the Cytokines in the Body Fluid (2026-01-13),
2. 11186629 - Treatment method for Cockayne syndrome (2021-11-30),
3. 9216386 - Sequential extracorporeal treatment of bodily fluids (2015-12-22),
4. 8865733 - Medication and treatment for disease (2014-10-21),
5. 8758287 - Utilization of stents for the treatment of blood borne carcinomas (2014-06-24),
6. 7473552 - Production of hydrogen gas and isolation of hydrogen producing microorganisms using replenishing coated substrates (2009-01-06),
7. 6274377 - Inducing apoptosis in a mammalian cell by contacting with paraffin or agar (2001-08-14),
8. 5962306 - Method of determining the presence or absence of a nonparaffinophilic (1999-10-05),
9. 5882920 - Apparatus for determining the presence or absence of a paraffinophilic (1999-03-16),
10. 5882919 - Apparatus for determining the presence or absence of a (1999-03-16),
11. 5854013 - Method of determining the presence or absence of a nonparaffinophilic (1998-12-29),
12. 5804406 - Determining sensitivity of paraffinophilic microorganisms to (1998-09-08),
13. 5801009 - Method for determining the antimicrobial agent sensitivity of a (1998-09-01),
14. 5750363 - Method for determining the antimicrobial agent sensitivity of a (1998-05-12),
15. 5726030 - Method for automatically testing the antibiotic sensitivity of a (1998-03-10),

Title: Innovations and Contributions of Mitchell S Felder

Introduction

Mitchell S Felder, based in Hermitage, Pennsylvania, is a highly accomplished inventor recognized for his significant contributions to the field of medical treatments. With a remarkable portfolio of 23 patents, Felder's work revolves around innovative methods for treating complex medical conditions.

Latest Patents

Among his latest patents, Felder has developed a groundbreaking treatment method for Cockayne Syndrome (CS). This invention involves the extracorporeal treatment of a patient's body fluid, wherein blood is removed from a CS patient and targeted antibodies are applied. The targeted components—including mammalian target of rapamycin (mTOR) antigen or death-associated protein 1 (DAP1)—create an antibody-antigen complex, which is subsequently purified and returned to the patient. This method aims to enhance the quality of treatment for patients suffering from this rare genetic disorder.

Additionally, Felder has patented a method for the sequential extracorporeal treatment of bodily fluids. This versatile method can be applied to blood, cerebral spinal fluid, and lymph, involving a two-stage process. Initially, the bodily fluid undergoes a treatment, which may include medication, thermal treatment, or irradiation. In the second stage, the treatment components are efficiently removed before the purified fluid is returned to the patient. The system is designed for continuous processes, akin to dialysis, enhancing patient safety and comfort.

Career Highlights

Felder's career has been marked by his association with innovative companies, including Infectech, Inc. and Marv Enterprises, LLC. His work in these organizations has been pivotal in translating his patents into viable treatments that can significantly impact patient care.

Collaborations

Throughout his journey as an inventor, Felder has collaborated with notable colleagues, such as Robert-A Ollar and Robert A Ollar. These partnerships have fostered a collaborative environment conducive to innovation, underscoring the importance of teamwork in advancing healthcare technologies.

Conclusion

Mitchell S Felder's impressive portfolio of patents emphasizes his dedication to medical innovation and patient improvement. His contributions, particularly in the treatment of complex conditions like Cockayne Syndrome, highlight the valuable intersection of research and practical applications in healthcare. As he continues to push the boundaries of medical treatments, Felder remains a significant figure in the world of inventors, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…